Amrita Vishwa Vidyapeetham has been ranked 9th in the medical category according to the National Institutional Ranking Framework (NIRF) 2025, a ranking released by the Ministry of Education, Government of India. This ranking reflects the institution's performance across several key parameters.
NIRF 2025 Analysis
The NIRF ranking assesses institutions based on various parameters. The scores achieved by Amrita Vishwa Vidyapeetham in these parameters are detailed below:
|
Parameter |
Score |
|
Teaching, Learning & Resources (TLR) |
80.06 |
|
Research and Professional Practice (RPC) |
49.86 |
|
Graduation Outcome (GO) |
88.06 |
|
Outreach and Inclusivity (OI) |
75.39 |
|
Perception |
43.92 |
Academic Programs
Amrita Vishwa Vidyapeetham offers both undergraduate (UG) and postgraduate (PG) programs. The sanctioned intake and actual student strength for specific programs are as follows:
Sanctioned Intake:
|
Academic Year |
UG [5 Years Program(s)] |
PG [3 Year Program(s)] |
|
2023-24 |
150 |
170 |
|
2022-23 |
150 |
161 |
|
2021-22 |
150 |
159 |
|
2020-21 |
100 |
- |
|
2019-20 |
100 |
- |
|
2018-19 |
- |
- |
Total Actual Student Strength:
|
Program |
Male Students |
Female Students |
Total Students |
Within State |
Outside State |
Outside Country |
Economically Backward |
Socially Challenged (SC+ST+OBC) |
|
UG [5 Years Program(s)] |
205 |
394 |
599 |
493 |
92 |
0 |
200 |
54 |
|
PG [3 Year Program(s)] |
197 |
250 |
447 |
375 |
71 |
0 |
105 |
28 |
Full Tuition Fee Reimbursement:
|
Program |
From State/Central Govt. |
From Institution Funds |
From Private Bodies |
Not Receiving Reimbursement |
|
UG [5 Years Program(s)] |
0 |
54 |
0 |
146 |
|
PG [3 Year Program(s)] |
0 |
28 |
0 |
77 |
Placement & Outcomes
Placement data for UG [5 Years Program(s)] over the past three academic years is as follows:
|
Academic Year |
Intake |
Admitted |
Lateral Entry |
Graduating |
Placed |
Median Salary (Rs.) |
Higher Studies |
|
|
2016-17 |
100 |
100 |
2017-18: 0 |
2020-21 |
92 |
92 |
550000 |
0 |
|
2017-18 |
100 |
100 |
2018-19: 0 |
2021-22 |
99 |
94 |
650000 |
5 |
|
2018-19 |
100 |
100 |
2019-20: 0 |
2022-23 |
83 |
83 |
720000 |
0 |
